Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: suvorexant
What it is used for
BELSOMRA is indicated for the treatment of insomnia, characterised by difficulties with sleep onset and/or sleep maintenance.,Following initiation of treatment, continuation should be re-evaluated after 3 months [see Pharmacodynamic Properties, Clinical trials and Adverse Effects (Undesirable Effects) for clinical trial durations].
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
White, oval, biconvex, film coated tablet, marked with MSD logo and 325 on one side and plain on the other side
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient suvorexant
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What Are Sleeping Tablets? Sleeping tablets work on pathways in the brain which are important in regulating whether someone is awake or asleep. Most sleeping tablets make the ‘sleep pathways’ more active. One of the newer medications works by making the ‘wake pathways’ less active. Sleeping tablets ge
Read more on Sleep Health Foundation website